Point-of-Care Guides

Syncope: Initial Evaluation and Prognosis



FREE PREVIEW Login or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.

Am Fam Physician. 2006 Oct 15;74(8):1367-1370.

Clinical Question

What is the prognosis and recommended initial evaluation for a patient with syncope?

Evidence Summary

Although syncope often is benign, it may have a serious underlying cause. An important question for primary care or emergency department physicians is whether the patient can be evaluated safely in the outpatient setting. Two clinical risk scores that can assist physicians in making this decision have been developed and validated. Both require electrocardiography (ECG) and a focused patient history and physical examination (see accompanying patient encounter form).

Initial Evaluation of Syncope Encounter Form

View Large

Initial Evaluation of Syncope Encounter Form

Initial Evaluation of Syncope Encounter Form

The first syncope rule (Table 11) was developed using prospective data collected from two groups of patients presenting to the emergency department with syncope between 1981 and 1991.1 All patients underwent a standardized assessment that included blood tests, prolonged ECG monitoring, and other studies that the treating physicians considered necessary. Four independent predictors of serious arrhythmia or death after one year were identified: abnormal ECG, age older than 45 years, history of congestive heart failure, and history of ventricular arrhythmia. Sinus bradycardia or tachycardia or nonspecific ST- or T-wave changes alone were not considered abnormal. The rule was developed in 251 patients and prospectively validated in 374 patients. The risk of death in the year after presentation ranged from 1 percent for patients with no risk factors to 27 percent for patients with three or more risk factors.1

TABLE 1

Clinical Risk Score for Predicting One-Year Mortality in Patients with Syncope

Risk factors

Abnormal electrocardiogram*

Age older than 45 years

History of congestive heart failure

History of ventricular arrhythmia

Number of risk factors One-year mortality rate (%)

0

1

1

9

2

16

3 or 4

27


*—Abnormal electrocardiogram does not include sinus bradycardia or tachycardia or nonspecific ST- or T-wave changes alone.

Information from reference 1.

TABLE 1   Clinical Risk Score for Predicting One-Year Mortality in Patients with Syncope

View Table

TABLE 1

Clinical Risk Score for Predicting One-Year Mortality in Patients with Syncope

Risk factors

Abnormal electrocardiogram*

Age older than 45 years

History of congestive heart failure

History of ventricular arrhythmia

Number of risk factors One-year mortality rate (%)

0

1

1

9

2

16

3 or 4

27


*—Abnormal electrocardiogram does not include sinus bradycardia or tachycardia or nonspecific ST- or T-wave changes alone.

Information from reference 1.

The San Francisco Syncope Rule (Table 22) was developed to identify patients at risk of serious outcomes (e.g., death, myocardial infarction, significant hemorrhage, pulmonary embolism, arrhythmia, stroke) within 30 days of presentation.2 The authors validated the rule with prospective data from a second group of 713 patients presenting to the emergency department with syncope. Patients with alcohol- or drug-related loss of consciousness, trauma, or definite seizure were excluded. The mean age of patients was 61 years, and 53 had a serious outcome during the 30-day follow-up. Five risk factors were identified: systolic blood pressure less than 90 mm Hg, shortness of breath, nonsinus rhythm or new changes present on ECG, history of congestive heart failure, and a hematocrit level less than 30 percent. Patients with any one risk factor had a 15.2 percent risk of serious outcome compared with a 0.3 percent risk for patients with no risk factors.2

TABLE 2

San Francisco Syncope Rule for Predicting Risk of Serious Outcomes

Risk factors

Systolic blood pressure less than 90 mm Hg

Shortness of breath

Electrocardiogram: nonsinus rhythm or new changes present

History of congestive heart failure

Hematocrit level less than 30 percent

Risk Number of patients with serious outcomes* within 30 days of presentation (%)

Low risk (no risk factors)

One out of 371 patients (0.3)

High risk (one or more risk factors)

52 out of 342 patients (15.2)


*—Serious outcomes include death, myocardial infarction, arrhythmia, pulmonary embolism, stroke, subarachnoid hemorrhage, significant hemorrhage, anemia requiring transfusion, procedural intervention to treat a related cause of syncope, or any condition that is likely to cause the patient to return to the emergency department.

Information from reference 2.

TABLE 2   San Francisco Syncope Rule for Predicting Risk of Serious Outcomes

View Table

TABLE 2

San Francisco Syncope Rule for Predicting Risk of Serious Outcomes

Risk factors

Systolic blood pressure less than 90 mm Hg

Shortness of breath

Electrocardiogram: nonsinus rhythm or new changes present

History of congestive heart failure

Hematocrit level less than 30 percent

Risk Number of patients with serious outcomes* within 30 days of presentation (%)

Low risk (no risk factors)

One out of 371 patients (0.3)

High risk (one or more risk factors)

52 out of 342 patients (15.2)


*—Serious outcomes include death, myocardial infarction, arrhythmia, pulmonary embolism, stroke, subarachnoid hemorrhage, significant hemorrhage, anemia requiring transfusion, procedural intervention to treat a related cause of syncope, or any condition that is likely to cause the patient to return to the emergency department.

Information from reference 2.

Two evidence-based guidelines address the initial evaluation of patients with syncope.3,4 The American College of Emergency Physicians (ACEP) recommends that patients older than 60 years with a history of cardiovascular disease or evidence of heart failure or cardiac outflow obstruction be considered at high risk of adverse outcomes.3 Patients younger than 45 years without cardiovascular disease or other risk factors should be considered at low risk. The ACEP recommends ECG if a history and physical examination do not reveal a diagnosis.3  The European Society of Cardiology recommends a similar evaluation and provides guidance regarding clinical symptoms that suggest specific causes of syncope (Table 3).4

TABLE 3

Clinical Features Suggesting Causes of Syncope

Type of syncope Clinical features

Neurally mediated (vasovagal)

Absence of cardiovascular disease

Long history of syncope episodes

Syncope occurs after sudden, unexpected, or unpleasant sight, sound, smell, or pain

Syncope occurs during prolonged standing, especially in crowded or hot places

Nausea or vomiting associated with syncope

Syncope occurs during a meal or in the absorptive state after a meal

Syncope occurs with head rotation or when there is pressure on carotid sinus (e.g., tumor, shaving, tight collar)

Syncope occurs after exertion

Cerebrovascular

Syncope occurs with arm exercise

Blood pressure or pulse difference between the two arms

Orthostatic-hypotension related

Syncope occurs after standing up

Temporal relationship with start of medication causing hypotension or dosage changes

Syncope occurs during prolonged standing, especially in crowded or hot places

Presence of autonomic neuropathy or parkinsonism

Syncope occurs after exertion

Cardiac

Presence of definite structural heart disease

Syncope occurs during exertion or when supine

Syncope preceded by palpitation

Family history of sudden death


Adapted with permission from Brignole M, Alboni P, Benditt DG, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, et al., for the Task Force on Syncope. European Society of Cardiology. Guidelines on management (diagnosis and treatment) of syncope—update 2004. Europace 2004;6:478.

TABLE 3   Clinical Features Suggesting Causes of Syncope

View Table

TABLE 3

Clinical Features Suggesting Causes of Syncope

Type of syncope Clinical features

Neurally mediated (vasovagal)

Absence of cardiovascular disease

Long history of syncope episodes

Syncope occurs after sudden, unexpected, or unpleasant sight, sound, smell, or pain

Syncope occurs during prolonged standing, especially in crowded or hot places

Nausea or vomiting associated with syncope

Syncope occurs during a meal or in the absorptive state after a meal

Syncope occurs with head rotation or when there is pressure on carotid sinus (e.g., tumor, shaving, tight collar)

Syncope occurs after exertion

Cerebrovascular

Syncope occurs with arm exercise

Blood pressure or pulse difference between the two arms

Orthostatic-hypotension related

Syncope occurs after standing up

Temporal relationship with start of medication causing hypotension or dosage changes

Syncope occurs during prolonged standing, especially in crowded or hot places

Presence of autonomic neuropathy or parkinsonism

Syncope occurs after exertion

Cardiac

Presence of definite structural heart disease

Syncope occurs during exertion or when supine

Syncope preceded by palpitation

Family history of sudden death


Adapted with permission from Brignole M, Alboni P, Benditt DG, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, et al., for the Task Force on Syncope. European Society of Cardiology. Guidelines on management (diagnosis and treatment) of syncope—update 2004. Europace 2004;6:478.

Applying the Evidence

A 68-year-old man presents in your office after an episode of syncope. He had just dressed for a special event and was wearing a tie for the first time in many years. The patient was nauseated and felt flushed after rising from the toilet, then his wife saw him fall to the floor. There was no seizure activity, and he regained consciousness within 15 seconds. He vomited once but felt somewhat better after drinking something and resting; he refused transport to the emergency department. He comes to your office the next day “to make sure nothing serious is wrong.” He denies any history of previous arrhythmia, heart failure, or heart disease, and he had no shortness of breath during the episode. He has normal blood pressure, cardiac examination, and ECG. His hematocrit level is 42 percent. What is his risk of short- and long-term adverse outcomes?

Answer: The patient only has one risk factor (his age) for one-year mortality and no risk factor for serious outcomes within 30 days of presentation. His symptoms suggest neurally mediated (vasovagal) syncope. You discuss this with the patient, and the two of you decide that no further evaluation is required at this time. If his symptoms recur or he develops additional symptoms, he agrees to see you immediately.

The Author

MARK H. EBELL, M.D., M.S., is in private practice in Athens, Ga., and is associate professor in the Department of Family Practice at Michigan State University College of Human Medicine, East Lansing. He also is deputy editor of evidence-based medicine for AFP.

E-mail correspondence to Mark H. Ebell, M.D., M.S., at ebell@msu.edu. Reprints are not available from the author.

REFERENCES

1. Martin TP, Hanusa BH, Kapoor WN. Risk stratification of patients with syncope. Ann Emerg Med. 1997;29:459–66.

2. Quinn J, McDermott D, Stiell I, Kohn M, Wells G. Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes. Ann Emerg Med. 2006;47:448–54.

3. American College of Emergency Physicians. Clinical policy: critical issues in the evaluation and management of patients presenting with syncope. Ann Emerg Med. 2001;37:771–6.

4. Brignole M, Alboni P, Benditt DG, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, et al., for the Task Force on Syncope. European Society of Cardiology. Guidelines on management (diagnosis and treatment) of syncope—update 2004. Europace. 2004;6:467–537.

This guide is one in a series that offers evidence-based tools to assist family physicians in improving their decision making at the point of care.


Copyright © 2006 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

More in AFP

More in Pubmed

Navigate this Article